Skip to main navigation Skip to search Skip to main content

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation

  • Universidade Federal do Rio Grande do Sul
  • Stanford University

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Autologous hematopoietic stem cell transplantation using genome-edited cells can become a definitive therapy for hematological and non-hematological disorders with neurological involvement. Proof-of-concept studies using human genome-edited hematopoietic stem cells have been hindered by the low efficiency of engraftment of the edited cells in the bone marrow and their modest efficacy in the CNS. To address these challenges, we tested a myeloablative conditioning regimen based on Busulfan in an immunocompromised model of mucopolysaccharidosis type 1. Compared with sub-lethal irradiation, Busulfan conditioning enhanced the engraftment of edited CD34+ cells in the bone marrow, as well the long-term homing and survival of bone-marrow-derived cells in viscera, and in the CNS, resulting in higher transgene expression and biochemical correction in these organs. Edited cell selection using a clinically compatible marker resulted in a population with low engraftment potential. We conclude that conditioning can impact the engraftment of edited hematopoietic stem cells. Furthermore, Busulfan-conditioned recipients have a higher expression of therapeutic proteins in target organs, particularly in the CNS, constituting a better conditioning approach for non-hematological diseases with neurological involvement.

Original languageEnglish
Pages (from-to)392-409
Number of pages18
JournalMolecular Therapy Methods and Clinical Development
Volume25
DOIs
StatePublished - 9 Jun 2022

Keywords

  • Busulfan
  • CRISPR-Cas9
  • conditioning
  • engraftment
  • genome editing
  • hematopoietic stem cell
  • iduronidase
  • lysosomal storage disease
  • mucopolysaccharidosis type I
  • tNGFR
  • total body irradiation

Fingerprint

Dive into the research topics of 'Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation'. Together they form a unique fingerprint.

Cite this